Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Pharma Intermediate. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN109081810A details a robust 7-step synthesis for Lorlatinib intermediates. Achieves high purity and scalable production for global pharmaceutical supply chains.
Patent CN102757367A details a cost-effective splitting process for DL-benzene ethyl sulfonic acid using L-HPG, offering high purity and supply chain stability for pharmaceutical intermediates.
Patent CN110818576B reveals a novel rare earth catalyzed synthesis of secondary amines. High yield, mild conditions, and cost-effective supply chain solutions for pharma.
Patent CN104725280B reveals ETS-10 catalyzed route for high purity diarylurea intermediates. Delivers cost effective supply chain solutions for global pharmaceutical manufacturing partners.
Patent CN102531987B reveals high-purity chiral intermediate synthesis. Enables cost reduction in pharma manufacturing with scalable supply chain solutions.
Advanced patent CN106478518A enables high-purity Rosuvastatin intermediate production with improved safety and scalability for global supply chains.
Patent CN102408392A details a green aqueous synthesis for 2-(N,N-disubstituted amino)-4-thiazolinone. This method offers high yields, reduced costs, and scalable production for pharma intermediates.
Novel resolution method for levodopa intermediate ensures high purity and cost efficiency. Reliable supply chain partner for pharmaceutical manufacturing needs.
Patent CN1634896A introduces a fixed-bed continuous method for piperazine synthesis, offering high selectivity and lower pressure operation for cost-effective pharmaceutical intermediate manufacturing.
Patent CN106046095B reveals mild Obeticholic acid synthesis. Eliminates LDA cryogenic steps. Enables cost reduction in pharmaceutical intermediates manufacturing.
Novel isoxazoline preparation via Lewis acid catalysis. Mild conditions, high purity, cost-effective manufacturing for pharmaceutical intermediates.
Patent CN102531987B reveals a high-purity synthesis route. This report analyzes cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN111560017B reveals efficient synthesis of azabicyclo alkanone dipeptide mimetics. Discover cost reduction and supply chain advantages for pharmaceutical manufacturing.
Novel quinoline salt dearomatization patent enables high-purity pharmaceutical intermediates. Discover cost-effective scalable synthesis routes for complex bridged polycyclic structures.
Novel Pd-catalyzed method offers high yield and mild conditions for pharmaceutical intermediate manufacturing supply chain optimization.
Patent CN1267410C reveals a safer, high-yield route for cyclohexanol derivatives using amidine catalysts, offering significant cost reduction in API manufacturing and supply chain reliability.
Novel copper photocatalysis method enables mild nitrogen-alkylation. Reduces costs and improves supply chain reliability for complex pharmaceutical intermediate manufacturing.
Patent CN102219825B details a rapid, high-yield synthesis of 3beta-hydroxy-16alpha,17alpha-epoxy-5-pregnene-20-one, offering significant cost and time advantages for steroid manufacturing.
Discover the novel chiral zinc-nitrogen complex from patent CN102887912A. Enhance asymmetric synthesis capabilities with our reliable supply of specialized catalytic intermediates.
Novel iodination method reduces cost and improves safety for liquid crystal intermediates. Reliable supply chain for high-purity pharmaceutical intermediates.